- Home
- BLRX vs RETO Comparison
BLRX vs RETO Comparison
Compare BLRX & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- RETO
- Stock Information
- Founded
- BLRX 2003
- RETO 1999
- Country
- BLRX Israel
- RETO China
- Employees
- BLRX N/A
- RETO N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- RETO Multi-Sector Companies
- Sector
- BLRX Health Care
- RETO Consumer Discretionary
- Exchange
- BLRX Nasdaq
- RETO Nasdaq
- Market Cap
- BLRX 36.0M
- RETO 33.0M
- IPO Year
- BLRX 2011
- RETO 2017
- Fundamental
- Price
- BLRX $0.48
- RETO $0.93
- Analyst Decision
- BLRX Strong Buy
- RETO
- Analyst Count
- BLRX 2
- RETO 0
- Target Price
- BLRX $11.50
- RETO N/A
- AVG Volume (30 Days)
- BLRX 407.5K
- RETO 99.3K
- Earning Date
- BLRX 11-29-2024
- RETO 12-26-2024
- Dividend Yield
- BLRX N/A
- RETO N/A
- EPS Growth
- BLRX N/A
- RETO N/A
- EPS
- BLRX N/A
- RETO N/A
- Revenue
- BLRX $17,048,000.00
- RETO $3,841,142.00
- Revenue This Year
- BLRX N/A
- RETO N/A
- Revenue Next Year
- BLRX N/A
- RETO N/A
- P/E Ratio
- BLRX N/A
- RETO N/A
- Revenue Growth
- BLRX N/A
- RETO N/A
- 52 Week Low
- BLRX $0.39
- RETO $0.86
- 52 Week High
- BLRX $1.93
- RETO $6.80
- Technical
- Relative Strength Index (RSI)
- BLRX 53.32
- RETO 31.60
- Support Level
- BLRX $0.40
- RETO $1.07
- Resistance Level
- BLRX $0.46
- RETO $1.15
- Average True Range (ATR)
- BLRX 0.03
- RETO 0.08
- MACD
- BLRX 0.01
- RETO -0.01
- Stochastic Oscillator
- BLRX 94.50
- RETO 12.12
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.